A analysis workforce at Aarhus College has developed a new molecule that attaches to the floor of SARS-CoV-2 virus particles. This attachment prevents the virus from getting into human cells and spreading the an infection.
The newly developed molecule belongs to a class of compounds generally known as RNA aptamers and it’s based mostly on the identical sort of constructing blocks which are used for mRNA vaccines. This makes them less expensive and simpler to fabricate than the antibodies which are at the moment used to deal with Covid-19 and to detect viral an infection utilizing speedy antigen checks.
An aptamer is a piece of DNA or RNA that folds into a 3D construction that may acknowledge a particular goal molecule of curiosity. By attaching itself to the virus floor, the RNA aptamer prevents the Spike protein from serving as a key that permits the virus to enter a cell.
Therefore, the RNA aptamer shouldn’t be a new sort of vaccine however a compound that may probably cease the virus from spreading within the physique as soon as somebody is uncovered to the virus.
The environment friendly binding to SARS-CoV-2 virus additionally implies that the aptamer can be utilized to check for covid-19 an infection.
“We’ve began testing the brand new aptamer in speedy checks and we count on to have the ability to detect very low concentrations of the virus,” says Professor Jørgen Kjems from Aarhus College who’s the primary creator of the article which has simply been revealed within the prestigious journal, PNAS.
Research in cell tradition present that the aptamer works in opposition to the earlier variants of coronavirus that the researchers had the chance to check.
“Since we submitted the article for peer overview, we now have continued our research and been capable of present that it additionally acknowledges the delta variant. Now we’re ready for samples of the newly recognized variant, omicron, so we are able to check whether or not the aptamer additionally acknowledges that,” says Jørgen Kjems.
He emphasizes, that the outcomes with the delta variant haven’t but been peer reviewed and revealed.
Reference: “A serum-stable RNA aptamer particular for SARS-CoV-2 neutralizes viral entry” by Julián Valero, Laia Civit, Daniel M. Dupont, Denis Selnihhin, Line S. Reinert, Manja Idorn, Brett A. Israels, Aleksandra M. Bednarz, Claus Bus, Benedikt Asbach, David Peterhoff, Finn S. Pedersen, Victoria Birkedal, Ralf Wagner, Søren R. Paludan and Jørgen Kjems, 7 December 2021, Proceedings of the Nationwide Academy of Sciences.
Funding: Carlsberg Basis, Danish Nationwide Analysis Basis, EU Horizon2020